<p><strong>Pregnancy</strong>&nbsp;Category B. Reproduction studies have been performed in female laboratory rabbits, mice, and rats at doses up to 1.3, 7, and 9 times themaximum daily human dose respectively and have revealed no evidence of impaired fertility or harm to the fetus due to maprotiline. There are, however, no adequate and well controlled studies in pregnant women. Be cause animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed.<br />
<br />
<strong>Labor and Delivery</strong>: Although the effect of maprotiline on labor and delivery is unknown, caution should be exercised as with any drug with CNS depressant action<br />
<br />
<strong>Nursing Mothers</strong>: Maprotiline is excreted in breast milk. At steady-state, the concentrations in milk correspond closely to the concentrations in whole blood. Caution should be exercised when maprotiline hydrochloride is administered to a nursing woman.</p>